CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a prostate cancer diagnostic kit that utilizes glycoprofiling of proteins with lectins. The aim is to provide a reliable second opinion for biopsy decisions, reducing unnecessary procedures and improving accuracy compared to traditional PSA tests.
The technology validation was successfully completed indicating a great commercial potential, and the innovative and inventive aspects of the assay platform are now covered by the filed priority European Patent Office (EPO) patent applications.
Validated glycoprofiling of the proteins now uses lectins in a format, fully compatible with clinical PSA assay kits.
This PoC grant focuses on 1.
Pre-clinical retrospective validation of the early stage biomarker of prostate cancer (PCa) and 2.
Commercia…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Slovakia, Bratislava
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
